One of the greatest hurdles for BioSense Onboarding is the process of validating data received to ensure it contains Data Elements of Interest (DEOI) needed for syndromic surveillance. Efforts to automate this process are critical to meet existing and future demands for facility onboarding requests as well as provide a foundation for data quality assurance efforts. By automating the validation process, BioSense hopes to:

1. Reduce costs associated with the iterative validation process.

2. Improve BioSense response times for assistance with onboarding.

3. Improve documentation to partners about requirements and communicate changes to DEOI.

4. Provide a better foundation for data quality initiatives.

Efforts to improve data validation are being developed in alignment with BioSense future initiatives and will apply to both BioSense, Essence and other BioSense program applications.

BioSense Onboarding identified critical success factors by participating in ISDS workgroup initiatives for Onboarding and Data Quality and soliciting feedback from key jurisdictional partners. These critical success factors include; improved documentation, access to raw data, and faster validation response time.

Objective

This session will inform the BioSense Community about data validation advancements implemented this past year as well as future plans to improve the BioSense validation process to achieve emergency department representativeness goals.